These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6358542)

  • 1. A randomized trial of propranolol in patients with acute myocardial infarction. II. Morbidity results.
    JAMA; 1983 Nov; 250(20):2814-9. PubMed ID: 6358542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propranolol therapy in patients with acute myocardial infarction: the Beta-Blocker Heart Attack Trial.
    Goldstein S
    Circulation; 1983 Jun; 67(6 Pt 2):I53-7. PubMed ID: 6342840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results.
    JAMA; 1982 Mar; 247(12):1707-14. PubMed ID: 7038157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of propranolol in non-Q-wave acute myocardial infarction in the beta blocker heart attack trial.
    Gheorghiade M; Schultz L; Tilley B; Kao W; Goldstein S
    Am J Cardiol; 1990 Jul; 66(2):129-33. PubMed ID: 2196771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of angina pectoris after myocardial infarction: comparison of "Rose Questionnaire" with physician judgment in the Beta-Blocker Heart Attack Trial.
    Friedman LM; Byington RP
    Am J Epidemiol; 1985 Apr; 121(4):555-62. PubMed ID: 3893101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persantine-Aspirin Reinfarction Study. Part II. Secondary coronary prevention with persantine and aspirin.
    Klimt CR; Knatterud GL; Stamler J; Meier P
    J Am Coll Cardiol; 1986 Feb; 7(2):251-69. PubMed ID: 2868029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of propanolol in patients entered in the Beta-Blocker Heart Attack Trial with their first myocardial infarction and persistent electrocardiographic ST-segment depression.
    Shivkumar K; Schultz L; Goldstein S; Gheorghiade M
    Am Heart J; 1998 Feb; 135(2 Pt 1):261-7. PubMed ID: 9489974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-blocker heart attack trial: design, methods, and baseline results. Beta-blocker heart attack trial research group.
    Byington RP
    Control Clin Trials; 1984 Dec; 5(4):382-437. PubMed ID: 6151483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The beta-blocker heart attack trial. beta-Blocker Heart Attack Study Group.
    JAMA; 1981 Nov; 246(18):2073-4. PubMed ID: 7026815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of prolonged ventricular repolarization following myocardial infarction: the BHAT experience. The BHAT Study Group.
    Peters RW; Byington RP; Barker A; Yusuf S
    J Clin Epidemiol; 1990; 43(2):167-72. PubMed ID: 2406377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta Blocker Heart Attack Trial: design features.
    Control Clin Trials; 1981 Dec; 2(4):275-85. PubMed ID: 6120793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abrupt withdrawal of beta-blockade therapy in patients with myocardial infarction: effects on infarct size, left ventricular function, and hospital course.
    Croft CH; Rude RE; Gustafson N; Stone PH; Poole WK; Roberts R; Strauss HW; Raabe DS; Thomas LJ; Jaffe AS
    Circulation; 1986 Jun; 73(6):1281-90. PubMed ID: 3009050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of propranolol in patients with myocardial infarction and ventricular arrhythmia.
    Friedman LM; Byington RP; Capone RJ; Furberg CD; Goldstein S; Lichstein E
    J Am Coll Cardiol; 1986 Jan; 7(1):1-8. PubMed ID: 3510232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the addition of propranolol to therapy with nifedipine for unstable angina pectoris: a randomized, double-blind, placebo-controlled trial.
    Gottlieb SO; Weisfeldt ML; Ouyang P; Achuff SC; Baughman KL; Traill TA; Brinker JA; Shapiro EP; Chandra NC; Mellits ED
    Circulation; 1986 Feb; 73(2):331-7. PubMed ID: 3510764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history of the first non-Q wave myocardial infarction in the placebo arm of the Beta-Blocker Heart Attack Trial.
    Gheorghiade M; Schultz L; Tilley B; Kao W; Goldstein S
    Am Heart J; 1991 Dec; 122(6):1548-53. PubMed ID: 1957749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta blockade after myocardial infarction: the Norwegian propranolol study in high-risk patients.
    Hansteen V
    Circulation; 1983 Jun; 67(6 Pt 2):I57-60. PubMed ID: 6342841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term treatment with metoprolol after myocardial infarction: effect on 3 year mortality and morbidity.
    Olsson G; Rehnqvist N; Sjögren A; Erhardt L; Lundman T
    J Am Coll Cardiol; 1985 Jun; 5(6):1428-37. PubMed ID: 3889100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-blockers after myocardial infarction: influence of first-year clinical course on long-term effectiveness.
    Viscoli CM; Horwitz RI; Singer BH
    Ann Intern Med; 1993 Jan; 118(2):99-105. PubMed ID: 8416325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superiority of verapamil to propranolol in stable angina pectoris: a double-blind, randomized crossover trail.
    Frishman WH; Klein NA; Strom JA; Willens H; LeJemtel TH; Jentzer J; Siegel L; Klein P; Kirschen N; Silverman R; Pollack S; Doyle R; Kirsten E; Sonnenblick EH
    Circulation; 1982 Jan; 65(1 Pt 2):I51-9. PubMed ID: 6796289
    [No Abstract]   [Full Text] [Related]  

  • 20. The importance of pre- and postinfarction angina on timolol-related reduction in mortality and reinfarction.
    Gundersen T; Kjekshus J
    Clin Cardiol; 1985 Feb; 8(2):87-92. PubMed ID: 3882290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.